Kyosuke Momoi

Organized a third party committee for a TSE Mothers listed company, and conducted the secretariat work for the committee in relation to the structuring of a compliance system and rules.

Advised the client in relation to the third-party allocation of new shares of more than JPY500 billion by a TSE listed company, gave a U.S. private equity fund strategic advice on various legal issues.

Advised the client on their bid for privatization of an International Airport in Japan.

Advised the client in the incorporation of a joint venture company in Malaysia, which is the first online security broker in that country.

Advised the client in the incorporation of a joint venture company with a startup in Silicon Valley, which is expected to launch a highly innovative online game portal site.

Advised on a co-investment and development project on drone technology with a Japanese innovative start-up company.

Advised on the negotiation of a sponsorship agreement with a well-known soccer club in Europe.

Advised on regulatory matters in Japan relating to merger of two of the largest pharmaceutical companies in the U.S.

Advised on the negotiation of co-development and licensing agreement on immunosuppressant with one of the largest pharmaceutical companies in the U.S.

Advised on the negotiation of several license agreements regarding a blockbuster immunosuppressant in the field of drug coated stent with medical device companies in various countries.

Advised foreign companies doing business in Japan on a wide range of corporate matters including privacy laws and reviewed general contractual documents and provisions, privacy policies, distribution agreements, website terms of use, etc.

Advised the client on an international arbitration matter involving a US$500 million dispute of a pharmaceutical license agreement, between a Japanese company and U.S. company.

Advised foreign companies on a wide range of Japanese regulatory and policy matters, including providing an analysis of the National Public Service Act and other regulatory issues and processes relating to contacts with the Japanese government, assistance with public bidding, and review of contracts with Japanese government agencies.

Advised a major U.S. precision machinery company under the Pharmaceutical and Medical Device Act of Japan regarding the sales of wearable products in Japan, which ultimately led to its commercialization.

Advised a global food company under the Food Sanitation Act and Food Labeling Act of Japan on the sale of drinks, dairy products and confectionery in Japan as well as related import and duties issues.

Advised large U.S. tech companies on key aspects of their wearable device products.

Represented a Japanese large tech company in a litigation case relating to defamation and privacy infringement claims against one of the largest media companies in the world.

Represented foreign defendants in a high-profile criminal case in Japan that received wide international media coverage.

Advised on the criminal defense of a senior employee of a large bank in Europe, who was investigated by FSA of the UK relating to LIBOR affairs.